Waverley Pharma Inc (WAVE) — Tangible Net Worth Ratio
Waverley Pharma Inc (WAVE) has a Tangible Net Worth Ratio of -647.8% as of September 2023. This metric is calculated by deducting intangible assets (CA$1.44 Million) from net assets (CA$192.30K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Waverley Pharma Inc (WAVE) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Waverley Pharma Inc Tangible Net Worth Ratio (2017–2022)
This chart shows how Waverley Pharma Inc's Tangible Net Worth Ratio has changed across 6 annual periods from 2017 to 2022. As of September 2023, the ratio stands at -647.8%, reflecting net assets of CA$192.30K with intangible assets of CA$1.44 Million CAD.
Annual Tangible Net Worth Ratio for Waverley Pharma Inc (2017–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Waverley Pharma Inc from 2017 to 2022, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Waverley Pharma Inc.
| Year | Tangible NW Ratio | Net Assets (CAD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | -53.9% | CA$1.09 Million | CA$1.68 Million | CA$2.69 Million | ▼ -55.6 pp |
| 2021 | 1.7% | CA$1.79 Million | CA$1.76 Million | CA$3.68 Million | ▼ -9.7 pp |
| 2020 | 11.4% | CA$2.04 Million | CA$1.81 Million | CA$3.49 Million | ▼ -23.4 pp |
| 2019 | 34.8% | CA$2.85 Million | CA$1.85 Million | CA$4.39 Million | ▼ -17.1 pp |
| 2018 | 51.9% | CA$3.97 Million | CA$1.91 Million | CA$5.24 Million | ▼ -13.3 pp |
| 2017 | 65.3% | CA$5.06 Million | CA$1.76 Million | CA$6.66 Million | — |